Marloes Vissers
Overview
Explore the profile of Marloes Vissers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vissers M, van de Garde M, He S, Brandsen M, Hendriksen R, Nicolaie M, et al.
J Infect Dis
. 2024 Jun;
230(6):1466-1475.
PMID: 38888894
Background: Young children and older adults are susceptible for invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. Pneumococcal protein-specific antibodies play a protective role against IPD; however, not much is...
2.
van Kasteren P, Gelderloos A, Nicolaie M, Den Hartog G, Vissers M, Luytjes W, et al.
Pathog Dis
. 2024 May;
82.
PMID: 38714349
Respiratory pathogens can cause severe disease and even death, especially in the very young and very old. Studies investigating their prevalence often focus on individuals presenting to healthcare providers with...
3.
Langereis J, Cremers A, Vissers M, van Beek J, Meis J, de Jonge M
Infect Immun
. 2018 Nov;
87(2).
PMID: 30455196
Nontypeable (NTHi) bacteria express various molecules that contribute to their virulence. The presence of phosphocholine (PCho) on NTHi lipooligosaccharide increases adhesion to epithelial cells and is an advantage for the...
4.
Vissers M, Wijmenga-Monsuur A, Knol M, Badoux P, van Houten M, van der Ende A, et al.
PLoS One
. 2018 Mar;
13(3):e0194823.
PMID: 29601605
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was replaced by PHiD-CV10 in 2011. Data on carriage prevalence of S. pneumoniae serotypes in children...
5.
Ederveen T, Ferwerda G, Ahout I, Vissers M, de Groot R, Boekhorst J, et al.
Microbiome
. 2018 Jan;
6(1):10.
PMID: 29325581
Background: While almost all infants are infected with respiratory syncytial virus (RSV) before the age of 2 years, only a small percentage develops severe disease. Previous studies suggest that the...
6.
Jans J, Unger W, Vissers M, Ahout I, Schreurs I, Wickenhagen A, et al.
Eur J Immunol
. 2017 Dec;
48(4):621-631.
PMID: 29266251
Interferon gamma (IFN-γ) plays an important role in the antiviral immune response during respiratory syncytial virus (RSV) infections. Monocytes and T cells are recruited to the site of RSV infection,...
7.
Vissers M, Ahout I, van den Kieboom C, van der Gaast-de Jongh C, Groh L, Cremers A, et al.
BMC Infect Dis
. 2016 Mar;
16:129.
PMID: 26983753
Background: Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infections in infants. A small percentage of the infected infants develops a severe infection, while most of...
8.
Vissers M, Ahout I, de Jonge M, Ferwerda G
Clin Vaccine Immunol
. 2015 Dec;
23(3):243-5.
PMID: 26656116
Maternal vaccination is currently considered a strategy against respiratory syncytial virus (RSV) infections. In RSV-infected infants, high mucosal IgG levels correlated better with reduced RSV load and lower mucosal CXCL10...
9.
Vissers M, Schreurs I, Jans J, Heldens J, de Groot R, de Jonge M, et al.
Cytokine
. 2015 Aug;
76(2):458-464.
PMID: 26253531
Respiratory syncytial virus (RSV) bronchiolitis is a major burden in infants below three months of age, when the primary immune response is mainly dependent on innate immunity and maternal antibodies....
10.
Vissers M, Hartman Y, Groh L, de Jong D, de Jonge M, Ferwerda G
Infect Immun
. 2014 Sep;
82(12):4952-8.
PMID: 25183734
Matrix metallopeptidase 9 (MMP-9) is a protease involved in the degradation of extracellular matrix collagen. Evidence suggests that MMP-9 is involved in pathogenesis during Streptococcus pneumoniae infection. However, not much...